New York-based virtual women's health provider Maven Clinic is partnering with health-tracking ring maker Oura to allow Oura Ring wearers to sync their data with the Maven platform. Maven Clinic is a ...

Viz.ai, a company involved in AI-backed imaging and care coordination, is collaborating with pharma giant Novartis to develop proprietary AI-powered workflows inside the Viz Oncology Suite. Viz.ai ...

Population health technology company Color announced it had laid off workers as it pivots focus away from COVID-19 testing. According to posts by former employees on LinkedIn, the company cut 300 jobs ...

Ellipsis Health, a company using AI voice agent technology, announced it has raised $45 million in a new Series A funding round. Salesforce, Khosla Ventures and CVS Health Ventures led the round.

Connor Glass, founder and CEO of Phantom Neuro, explains how the company's muscle-machine interface for amputees is enabling the development of advanced prosthetic limbs designed to function as ...

Editor's note: This article has been updated with a comment from Hims & Hers CEO and the company. Pharma giant Novo Nordisk announced that it is terminating its contract with direct-to-consumer ...

"The FDA's clearance of SleepioRx is a landmark milestone for Big Health and provides accessible, guideline-recommended, first-line treatment for insomnia." Big Health CEO Yael Berman said in a ...

BrainCheck, a digital health company specializing in cognitive assessments, announced it secured $15 million in funding. The investment was led by seed-stage investor Next Coast Ventures, venture ...

By HIMSS TV September 25, 2024 06:00 am Share Tags: clinical AI ...

InSilicoTrials, a health tech company that develops AI-based simulation to predict drug safety and efficacy in the drug development process, announced it has been accepted into the Microsoft for ...

Elephas, an oncology-focused diagnostics platform, announced it secured $55 million in Series C funding, bringing its total raise to $116.5 million. Venture Investors Health Fund and the State of ...

The partnership has been terminated less than two months after launch as Novo Nordisk alleges Hims & Hers is illegally selling copycat drugs and using deceptive marketing practices.